363 related articles for article (PubMed ID: 28173828)
21. LncRNA MALAT1 promotes oxidized low-density lipoprotein-induced autophagy in HUVECs by inhibiting the PI3K/AKT pathway.
Li S; Pan X; Yang S; Ma A; Yin S; Dong Y; Pei H; Bi X; Li W
J Cell Biochem; 2019 Mar; 120(3):4092-4101. PubMed ID: 30485490
[TBL] [Abstract][Full Text] [Related]
22.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
23. Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism.
Zhong GX; Gong Y; Yu CJ; Wu SF; Ma QP; Wang Y; Ren J; Zhang XC; Yang WH; Zhu W
Tumour Biol; 2015 Jun; 36(6):4689-97. PubMed ID: 25619477
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast-derived CXCL12/SDF-1α promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K/Akt/mTOR pathway in colon cancer.
Ma JC; Sun XW; Su H; Chen Q; Guo TK; Li Y; Chen XC; Guo J; Gong ZQ; Zhao XD; Qi JB
World J Gastroenterol; 2017 Jul; 23(28):5167-5178. PubMed ID: 28811711
[TBL] [Abstract][Full Text] [Related]
25. Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.
Coco S; Truini A; Alama A; Dal Bello MG; Venè R; Garuti A; Carminati E; Rijavec E; Genova C; Barletta G; Sini C; Ballestrero A; Boccardo F; Grossi F
Target Oncol; 2015 Sep; 10(3):393-404. PubMed ID: 25341405
[TBL] [Abstract][Full Text] [Related]
26. Brain derived neurotrophic factor induces endothelial cells angiogenesis through AKT and ERK1/2 signal pathway.
Wang YD; Hu Y; Zhang L; Sun CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):175-80. PubMed ID: 18315925
[TBL] [Abstract][Full Text] [Related]
27. Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway.
Yang L; Xiao M; Li X; Tang Y; Wang YL
Int J Mol Med; 2016 Mar; 37(3):734-42. PubMed ID: 26847718
[TBL] [Abstract][Full Text] [Related]
28. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
[TBL] [Abstract][Full Text] [Related]
29. Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma.
Liu Y; Yang H; Chen T; Luo Y; Xu Z; Li Y; Yang J
PLoS One; 2015; 10(5):e0127092. PubMed ID: 25978653
[TBL] [Abstract][Full Text] [Related]
30. MEG3 damages fetal endothelial function induced by gestational diabetes mellitus via AKT pathway.
Ye HH; Yang SH; Zhang Y
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8553-8560. PubMed ID: 30575893
[TBL] [Abstract][Full Text] [Related]
31. Expression of HYOU1 via Reciprocal Crosstalk between NSCLC Cells and HUVECs Control Cancer Progression and Chemoresistance in Tumor Spheroids.
Lee M; Song Y; Choi I; Lee SY; Kim S; Kim SH; Kim J; Seo HR
Mol Cells; 2021 Jan; 44(1):50-62. PubMed ID: 33455947
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways.
Song ZY; Wang F; Cui SX; Qu XJ
Cancer Invest; 2018 Jan; 36(1):10-18. PubMed ID: 29381400
[TBL] [Abstract][Full Text] [Related]
33. [High D-glucose alters PI3K and Akt signaling and leads to endothelial cell migration, proliferation and angiogenesis dysfunction].
Yu P; Yu DM; Qi JC; Wang J; Zhang QM; Zhang JY; Tang YZ; Xing QL; Li MZ
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3425-30. PubMed ID: 17313857
[TBL] [Abstract][Full Text] [Related]
34. RasGRP1 is a target for VEGF to induce angiogenesis and involved in the endothelial-protective effects of metformin under high glucose in HUVECs.
Xu J; Liu M; Yu M; Shen J; Zhou J; Hu J; Zhou Y; Zhang W
IUBMB Life; 2019 Sep; 71(9):1391-1400. PubMed ID: 31120617
[TBL] [Abstract][Full Text] [Related]
35. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.
Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX
Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511
[TBL] [Abstract][Full Text] [Related]
36. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
[TBL] [Abstract][Full Text] [Related]
37. ELABELA improves endothelial cell function via the ELA-APJ axis by activating the PI3K/Akt signalling pathway in HUVECs and EA.hy926 cells.
Wang X; Liang G; Guo Q; Cai W; Zhang X; Ni J; Tao Y; Niu X; Chen S
Clin Exp Pharmacol Physiol; 2020 Dec; 47(12):1953-1964. PubMed ID: 32687618
[TBL] [Abstract][Full Text] [Related]
38. 5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells.
Kim KM; Heo DR; Lee J; Park JS; Baek MG; Yi JM; Kim H; Bang OS
Chem Biol Interact; 2015 Jan; 225():32-9. PubMed ID: 25446852
[TBL] [Abstract][Full Text] [Related]
39. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway.
Yin Y; Sui C; Meng F; Ma P; Jiang Y
Lipids Health Dis; 2017 May; 16(1):87. PubMed ID: 28468627
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of metabotropic glutamate receptor 1 suppresses tumor growth and angiogenesis in experimental non-small cell lung cancer.
Xia H; Zhao YN; Yu CH; Zhao YL; Liu Y
Eur J Pharmacol; 2016 Jul; 783():103-11. PubMed ID: 27132814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
